This trial is active, not recruiting.

Condition healthy
Treatment questionnaire
Sponsor M.D. Anderson Cancer Center
Collaborator National Cancer Institute (NCI)
Start date June 2004
End date December 2017
Trial size 1500 participants
Trial identifier NCT00476632, 2004-0112, 5RO1CA070917-08, P50 CA100632


The goal of this research study is to identify biologic and lifestyle factors that may increase a person's risk of developing certain types of cancer.


1. Enroll healthy participants who can serve as controls for approved IRB case-control protocols ID00-098 and ID03-0250.

2. Obtain detailed risk factor and food frequency questionnaires.

3. Collect and store blood samples on all participants.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Observational model case control
Time perspective prospective
Person with no history of cancer.
questionnaire Survey
50 Minute Interview

Primary Outcomes

To identify biologic and lifestyle factors that may increase a person's risk of developing certain types of cancer.
time frame: 6 Years

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: 1. Individuals ages 18 and over with no prior cancer 2. Willing and able to complete an administered questionnaire 3. Willing and able to donate 30 mL of blood Exclusion Criteria: 1. Individuals with prior cancer 2. Individuals under the age of 18

Additional Information

Official title Epidemiology Controls Using Healthy Participants
Principal investigator Sara Strom, PHD
Description For this study, you will be asked to complete a personal interview. During the interview, you will be asked questions about your demographics (age, sex, etc.), certain environmental exposures, your medical history, family history, your diet, and your smoking and alcohol use histories. It should take around 50 minutes to complete the interview. You will also have around 2 ½ tablespoons of blood drawn for special tests. These tests will look for any biologic factors associated with certain cancers. The interview and blood draw will be scheduled at the time and place of your convenience. You will not be informed of the results of any of the testing done with your samples. There is a possibility that you might be contacted in the future about if researchers need clarification on any of information already collected. You are free to refuse any further participation if you wish. This is an investigational study. Up to 1,500 participants will take part in this study.
Trial information was received from ClinicalTrials.gov and was last updated in October 2015.
Information provided to ClinicalTrials.gov by M.D. Anderson Cancer Center.